We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CELSION DRAWS WARNING FOR PROLIEVE TRIAL ACTIVTIES
CELSION DRAWS WARNING FOR PROLIEVE TRIAL ACTIVTIES
May 28, 2004
Biotechnology firm Celsion revealed last week that it had received an FDA warning letter regarding violations in the Phase I and II trials of its Prolieve Thermodilatation system, which received marketing approval from the agency in February.